...
首页> 外文期刊>Respiratory Research >Capillary pCO2 helps distinguishing idiopathic pulmonary arterial hypertension from pulmonary hypertension due to heart failure with preserved ejection fraction
【24h】

Capillary pCO2 helps distinguishing idiopathic pulmonary arterial hypertension from pulmonary hypertension due to heart failure with preserved ejection fraction

机译:毛细血管pCO 2 有助于区分特发性肺动脉高压和心力衰竭导致的肺动脉高压,并保留射血分数

获取原文
           

摘要

RationaleThe demographics of patients with idiopathic pulmonary arterial hypertension (IPAH) are changing and this diagnosis is increasingly being made in older patients. However, diagnostic misclassifications are common as it may be difficult to differentiate between IPAH and pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF). We investigated the hypothesis that the capillary pCO2 (pcCO2) may help distinguishing between idiopathic pulmonary arterial hypertension (IPAH) and pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF).MethodsIn a cross-sectional study, we retrospectively assessed pcCO2 levels (obtained from arterialized capillary blood at the time of diagnosis) from patients with IPAH or PH-HFpEF, respectively. Receiver operated characteristics (ROC) were used to determine the pcCO2 level providing the best discrimination between these two conditions. PcCO2 values were considered helpful if they were associated with a negative predictive value >0.9 to excluded either IPAH or PH-HFpEF.ResultsThe study enrolled 185 patients, 99 with IPAH (74% female; age 47?±?17?years; body mass index 26?±?5?kg/m2, PAPm 53?±?12?mmHg, PAWP 8?±?3?mmHg), and 86 with PH-HFpEF (64% female; age 69?±?10?years; body mass index 30?±?6?kg/m2, PAPm 47?±?10?mmHg, PAWP 21?±?5?mmHg). PcCO2 at time of diagnosis was 33?±?4?mmHg in the IPAH group and 40?±?5?mmHg in the PH-HFpEF group (p??41?mmHg.ConclusionsPcCO2 levels were significantly lower in IPAH compared to PH-HFpEF and may provide useful information in differentiating between both conditions.
机译:基本原理特发性肺动脉高压(IPAH)患者的人口统计数据正在发生变化,这种诊断在老年患者中越来越多。但是,由于心力衰竭且射血分数(PH-HFpEF)保持不变,可能难以区分IPAH和肺动脉高压,因此诊断错误分类很常见。我们调查了毛细血管pCO2(pcCO2)可能有助于区分特发性肺动脉高压(IPAH)和因心力衰竭而保留射血分数(PH-HFpEF)的肺动脉高压的方法。方法在一项横断面研究中,我们回顾性评估了pcCO2。患有IPAH或PH-HFpEF的患者的血脂水平(在诊断时从动脉毛细血管血中获取)。接收器操作特性(ROC)用于确定pcCO2水平,从而在这两个条件之间提供最佳区分。如果PcCO2值与阴性预测值> 0.9相关联以排除IPAH或PH-HFpEF,则被认为是有帮助的。结果该研究招募了185例患者,其中99例为IPAH(女性74%;年龄47?±17岁;体重)。指数26?±?5?kg / m2,PAPm 53?±?12?mmHg,PAWPm 8?±?3?mmHg),PH-HFpEF为86(女性64%;年龄69?±?10?岁;体重指数为30±6?kg / m2,PAPm 47±10?mmHg,PAWP 21±5?mmHg)。 IPAH组诊断时的PcCO2为33?±?4?mmHg,PH-HFpEF组为40?±?5?mmHg(p ?? 41?mmHg。)结论IPAH中的PcCO2水平明显低于PH-HFpEF组。 HFpEF和可能提供区分两种情况的有用信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号